Cipla USA, Inc. has recalled 13,680 ampoules of Budesonide Inhalation Suspension (0.5mg/2ml), a prescription medication used for breathing conditions. The recall was triggered by a report of leaking and empty ampoules, which means the sterile seal of the medicine could be compromised. The medication is sold in cartons of 30 single-dose ampoules, with five ampoules per pouch. If you use this medication, you should consult your doctor or pharmacist regarding your treatment.
If the sterile seal of an inhalation medication is broken, the liquid can become contaminated with bacteria or other germs. Using a non-sterile product in a nebulizer can cause serious respiratory infections, especially in patients who already have weakened lungs or immune systems.
You have 2 options:
Manufactured by Cipla Ltd. Indore SEZ, Pithampur, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.